Cargando…
The Role of Leptin in Antipsychotic-Induced Weight Gain: Genetic and Non-Genetic Factors
Schizophrenia is a chronic and disabling mental illness affecting millions of people worldwide. A greater proportion of people with schizophrenia tends to be overweight. Antipsychotic medications have been considered the primary risk factor for obesity in schizophrenia, although the mechanisms by wh...
Autores principales: | Panariello, Fabio, Polsinelli, Gina, Borlido, Carol, Monda, Marcellino, De Luca, Vincenzo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi Publishing Corporation
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3317122/ https://www.ncbi.nlm.nih.gov/pubmed/22523667 http://dx.doi.org/10.1155/2012/572848 |
Ejemplares similares
-
Peripheral Amino Acid Levels in Schizophrenia and Antipsychotic Treatment
por: De Luca, Vincenzo, et al.
Publicado: (2008) -
Weight Gain, Schizophrenia and Antipsychotics: New Findings from Animal Model and Pharmacogenomic Studies
por: Panariello, Fabio, et al.
Publicado: (2011) -
Leptin and psychiatric illnesses: does leptin play a role in antipsychotic-induced weight gain?
por: Endomba, Francky Teddy, et al.
Publicado: (2020) -
Genetic association of the rs17782313 polymorphism with antipsychotic-induced weight gain
por: Schreyer, Korbinian Felix, et al.
Publicado: (2023) -
S2. ANTIPSYCHOTICS RESULT IN WEIGHT GAIN BUT THE SEVERITY OF WEIGHT GAIN DIFFERS BETWEEN ANTIPSYCHOTICS
por: Bak, Maarten, et al.
Publicado: (2020)